South Korea Porcine Vaccines Market Research Report By Type (Inactivated vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, DNA vaccines), By Disease Indication (PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), Swine influenza, Aujeszky's disease (AD), Porcine Circovirus Associated Disease (PCVAD), Others) and By End-user (Veterinary Hospitals, Hog Production Farm)- Forecast to 2035

South Korea Porcine Vaccines Market Overview

As per MRFR analysis, the South Korea Porcine Vaccines Market Size was estimated at 44.75 (USD Million) in 2023. The South Korea Porcine Vaccines Market Industry is expected to grow from 48(USD Million) in 2024 to 120 (USD Million) by 2035. The South Korea Porcine Vaccines Market CAGR (growth rate) is expected to be around 8.687% during the forecast period (2025 - 2035)

Key South Korea Porcine Vaccines Market Trends Highlighted

The South Korea porcine vaccine market is growing rapidly due to increased concern over animal health, food safety, and biosecurity on the part of pig farmers. Further exacerbating the problem were escalations in the cases of porcine diseases such as African Swine Fever, which require proper vaccination programs to be implemented. Moreover, the sustained attempts of the South Korean government to promote livestock farming with the aid of R&D resources in veterinary medicine are increasingly shedding light on these areas. There exists a need for comprehensive vaccination programs that can keep pace with new evolving strains of diseases affecting pigs. There is also scope for the application of biotechnology to enhance vaccine potency.

In the region, there is a growing concern for the welfare of animals, which has a positive impact on the demand for vaccines aimed at making livestock healthier. Moreover, the government policy has been supporting the initiative to modernize farming by expanding the use of health management systems, such as vaccination programs. Investment is being directed into the regional production facilities for the vaccines in the context of productivity-enhancing initiatives that aim at maintaining a balanced farm ecosystem. There is also increasing collaboration between the government and private sectors for the development and improvement of vaccines. These public policies, combined with the focus on disease prevention and stringent legal frameworks, are anticipated to foster the productive development of the market for porcine vaccines in South Korea. As farmers gradually understand the economic value provided by vaccination programs, this is expected to improve the overall stability and productivity of the pork industry in the region.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

South Korea Porcine Vaccines Market Drivers

Increasing Demand for Animal Protein Consumption

In South Korea, the rising population and changing dietary preferences have led to an increased demand for animal protein, particularly pork. According to the Ministry of Agriculture, Food and Rural Affairs in South Korea, pork consumption accounts for nearly 60% of total meat consumption in the country. This escalating demand for pork increases the necessity for effective vaccinations in pig farming to ensure livestock health and prevent disease outbreaks, thus driving the South Korea Porcine Vaccines Market Industry.

The rising number of pig farms is also a significant factor, with approximately 6,200 registered pig farms as of the latest government report, further supporting the market growth of porcine vaccines as farmers aim to improve the health and productivity of their herds.

Government Initiatives and Support for Livestock Health

The South Korean government has prioritized livestock health through various initiatives and programs. A recent policy introduced by the Ministry of Agriculture aims to enhance biosecurity measures across pig farms, which includes the establishment of vaccination protocols and funding for research initiatives on vaccine development. Government investment in the Veterinary Sector, which reached over USD 100 million in 2022, underscores commitment to improving livestock management practices, including the adoption of porcine vaccines. This proactive governmental stance serves to bolster the South Korea Porcine Vaccines Market Industry as farmers are encouraged to adopt vaccination as a key component for disease prevention in swine.

Rising Incidence of Porcine Diseases

The emergence and re-emergence of porcine diseases, such as African Swine Fever (ASF) and Porcine Respiratory Disease Complex (PRDC), have heightened the focus on vaccination among farmers in South Korea. The Animal and Plant Quarantine Agency reported that South Korea experienced outbreaks of ASF in 2019, leading to significant economic implications and loss in the swine population. The urgent need for preventive measures against these diseases has prompted an increased willingness among pig farmers to invest in effective vaccines, thus stimulating growth in the South Korea Porcine Vaccines Market Industry. The demand for innovative vaccines to counter these prevalent diseases is expected to rise in line with the authorities' implementation of stringent biosecurity measures.

Technological Advancements in Vaccine Development

Technological advancements in vaccine development, such as the emergence of recombinant vaccines and DNA-based vaccines, are contributing to the growth of the South Korea Porcine Vaccines Market Industry. Companies engaged in Research and Development, such as LG Chem and Hanall Biopharma, are actively investing in innovative solutions to enhance vaccine efficacy and safety. The recent approval of a new vaccine formulation that has shown a 30% improvement in efficacy compared to traditional vaccines has been well-received in the market. Such improvements not only address health concerns but also build trust among farmers, further driving the demand for porcine vaccines in South Korea’s rapidly evolving livestock industry.

South Korea Porcine Vaccines Market Segment Insights

Porcine Vaccines Market Type Insights

The South Korea Porcine Vaccines Market exhibits a diverse and intricate landscape, particularly when examining the Type segment. This market is influenced by multiple factors, including the increasing demand for effective animal health solutions in the livestock sector, driven by the growing concerns over animal diseases and the safety of meat products. 

Inactivated vaccines play a significant role as they provide robust immunity to pigs without causing disease, making them a preferred choice among farmers. Live attenuated vaccines, on the other hand, are valued for their ability to stimulate a strong immune response with fewer doses compared to inactivated forms, thus appealing to producers looking for cost-effective solutions.Toxoid vaccines are particularly important as they target specific toxins produced by pathogens, ensuring that pigs develop immunity against these harmful substances without the risk of disease transmission. 

Recombinant vaccines represent an innovative approach in the South Korea Porcine Vaccines Market; they are designed to produce specific antigens, thereby enhancing both safety and efficacy. Conjugate vaccines are gaining traction as they improve immune responses by linking polysaccharides to proteins, offering a more robust defense mechanism against infections.Lastly, DNA vaccines are emerging as a novel solution, allowing for the rapid development of vaccines that prompt an immune response without using live pathogens, which aligns well with the industry's shift towards safer and more effective animal health management. 

The increasing investment in Research and Development, coupled with supportive government initiatives in South Korea, further stimulates growth in these segments as the industry continuously strives to enhance productivity and mitigate the impact of diseases in the swine population.The overall dynamics of the South Korea Porcine Vaccines Market Type segmentation reflects a focused approach towards improving livestock health, fostering innovation, and responding to the evolving needs of the agricultural sector.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Porcine Vaccines Market Disease Indication Insights

The South Korea Porcine Vaccines Market, with a significant focus on disease indications, is shaped by various critical factors influencing the health of swine populations. Conditions such as Porcine Epidemic Diarrhea (PED) and Porcine Reproductive and Respiratory Syndrome (PRRS) are notable contributors to increasing vaccine demand, as these diseases can lead to high mortality rates and economic losses for farmers. The prevalence of Swine influenza and Aujeszky's disease also necessitates effective vaccination strategies to mitigate outbreaks. In addition, the impact of Porcine Circovirus Associated Disease (PCVAD) continues to challenge producers, leading to a push for innovative vaccine solutions amidst rising herd protection needs.

The South Korean market is characterized by a concerted effort to enhance biosecurity measures driven by government policies promoting animal health and welfare. As agricultural practices evolve, the demand for effective vaccination against these diseases remains critical, signifying the importance of research and development efforts focused on vaccine advancements within the market. This landscape highlights a continuous opportunity for growth within the South Korea Porcine Vaccines Market as producers seek to safeguard their livestock against these prevalent diseases.

Porcine Vaccines Market End-user Insights

The South Korea Porcine Vaccines Market has a prominent focus on the End-user segment, with key contributors being Veterinary Hospitals and Hog Production Farms. Veterinary Hospitals play a vital role in administering vaccines and ensuring proper health standards for pigs, thus enhancing livestock health management. The increasing number of veterinary practices within the country supports the growth of porcine vaccines as more facilities adopt advanced healthcare solutions for livestock. Conversely, Hog Production Farms dominate the landscape as they are responsible for the majority of swine production.These farms require an effective vaccination strategy to minimize disease outbreaks and improve overall productivity. 

The growing demand for pork in South Korea, driven by a rising population and changing dietary preferences, places an added emphasis on maintaining herd health and biosecurity measures. The collaboration between veterinary professionals and hog farmers is essential for implementing vaccination programs that can mitigate diseases, ensuring both animal welfare and economic stability within the industry. Overall, the End-user segment demonstrates significant potential within the South Korea Porcine Vaccines Market, driven by the need for robust animal health solutions and increased production efficiency.

South Korea Porcine Vaccines Market Key Players and Competitive Insights

The competitive landscape of the South Korea Porcine Vaccines Market is characterized by a growing need for innovative solutions to combat prevalent diseases affecting swine populations. The market has experienced significant expansion due to increasing pork consumption and heightened awareness among livestock producers regarding the importance of vaccination in maintaining herd health. As the demand for high-quality pork escalates, the importance of reliable vaccine options for swine has come to the forefront. This has encouraged several players to enhance their research and development capabilities while also focusing on the establishment of strategic partnerships to reinforce their market position. 

Given the specific challenges posed by diseases such as Porcine Reproductive and Respiratory Syndrome, the need for effective vaccination strategies is increasingly paramount in the region.Hipra holds a notable position within the South Korea Porcine Vaccines Market, featuring an established portfolio of vaccines specifically designed for swine diseases. The company's strengths lie in its robust research and development framework, enabling the introduction of innovative vaccines that cater to the unique requirements of local livestock producers. Hipra has built solid relationships with local veterinarians and animal health professionals, enhancing its market presence through effective collaboration. 

Additionally, the company's commitment to quality assurance and regulatory compliance has reinforced the trust of local stakeholders, ensuring a competitive edge in terms of product reliability and effectiveness. Hipra's investment in local production facilities further signifies its dedication to addressing the demands of the South Korean market while fostering sustainable practices within the industry.Phibro Animal Health has also made significant inroads into the South Korea Porcine Vaccines Market, focusing on delivering a comprehensive range of products aimed at enhancing swine health. 

The company is recognized for its vaccine offerings that target systemic and respiratory diseases, which remain critical concerns for Korean pig farmers. Phibro's strengths stem from its innovative approach to vaccine development, backed by substantial resources dedicated to research and clinical studies. Additionally, the company actively seeks opportunities for growth through strategic mergers and acquisitions, integrating advanced technologies, and expanding its product lines in alignment with market needs. Phibro’s established distribution network in South Korea enables it to respond quickly to market demands, enhancing its service delivery and customer engagement.

Key Companies in the South Korea Porcine Vaccines Market Include

• Hipra


• Phibro Animal Health


• Virbac


• Cegelec


• Neogen Corporation


• Lohmann Animal Health


• Ceva Santé Animale


• Msd Animal Health


• Zoetis


• Elanco


• IDT Biologika


• Merck Animal Health


• Vaxxinova


• Boehringer Ingelheim

South Korea Porcine Vaccines Market Industry Developments

The South Korea Porcine Vaccines Market has witnessed notable developments, particularly with advances in vaccine technology aimed at enhancing swine health and productivity. Recent initiatives from companies like Zoetis, Merck Animal Health, and Boehringer Ingelheim have focused on innovative vaccine formulations to control prevalent swine diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS). In terms of market dynamics, a significant partnership was formed in August 2023 between Virbac and a leading South Korean research institution to bolster R&D in advanced vaccine strategies.

Additionally, Hipra has expanded its production capacity in South Korea to meet rising domestic and export demands, reflecting the increasing awareness of biosecurity among swine farmers. The market has been positively influenced by a 15% annual growth rate in the adoption of vaccination programs in swine, as reported by the Ministry of Agriculture, Food and Rural Affairs. In July 2023, Phibro Animal Health announced an acquisition of a local biotech firm, enhancing its product portfolio in the region. These trends underscore South Korea's commitment to strengthening its animal health landscape, driven by innovation and collaboration among leading companies.

South Korea Porcine Vaccines Market Segmentation Insights

• Porcine Vaccines Market Type Outlook
  
  
  
  • Inactivated vaccines
  
  
  • Live attenuated vaccines
  
  
  • Toxoid vaccines
  
  
  • Recombinant vaccines
  
  
  • Conjugate vaccines
  
  
  • DNA vaccines
  
  
  
  


• Porcine Vaccines Market Disease Indication Outlook
  
  
  
  • PED (Porcine Epidemic Diarrhea)
  
  
  • PRRS (Porcine Reproductive & Respiratory Syndrome)
  
  
  • Swine influenza
  
  
  • Aujeszky's disease (AD)
  
  
  • Porcine Circovirus Associated Disease (PCVAD)
  
  
  • Others
  
  
  
  


• Porcine Vaccines Market End-user Outlook
  
  
  
  • Veterinary Hospitals
  
  
  • Hog Production Farm
  
  
  
  

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	44.75(USD Million)
MARKET SIZE 2024	48.0(USD Million)
MARKET SIZE 2035	120.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	8.687% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Hipra, Phibro Animal Health, Virbac, Cegelec, Neogen Corporation, Lohmann Animal Health, Ceva Santé Animale, Msd Animal Health, Zoetis, Elanco, IDT Biologika, Merck Animal Health, Vaxxinova, Boehringer Ingelheim
SEGMENTS COVERED	Type, Disease Indication, End-user
KEY MARKET OPPORTUNITIES	Increased innovative vaccine development, Rising demand for disease prevention, Expansion of domestic swine industry, Growing awareness on animal health, Government support for vaccination programs
KEY MARKET DYNAMICS	rising porcine disease outbreaks, increased awareness of vaccine benefits, government support for livestock health, technological advancements in vaccine development, growing demand for safe pork products
COUNTRIES COVERED	South Korea